These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
716 related articles for article (PubMed ID: 20463340)
1. Hospital-acquired infections due to gram-negative bacteria. Peleg AY; Hooper DC N Engl J Med; 2010 May; 362(19):1804-13. PubMed ID: 20463340 [No Abstract] [Full Text] [Related]
2. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981 [TBL] [Abstract][Full Text] [Related]
3. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections. Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of lower respiratory tract infections in elderly]. Iakovlev SV Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539 [No Abstract] [Full Text] [Related]
6. The role of gram-negative bacteria in healthcare-associated pneumonia. Restrepo MI; Anzueto A Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188 [TBL] [Abstract][Full Text] [Related]
7. Infection in cirrhosis: A prospective study. Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968 [TBL] [Abstract][Full Text] [Related]
8. A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection. Rattanaumpawan P; Tolomeo P; Bilker WB; Lautenbach E Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1124-6. PubMed ID: 22011542 [TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study. Ting SW; Lee CH; Liu JW J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563 [TBL] [Abstract][Full Text] [Related]
10. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients. Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S; Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817 [TBL] [Abstract][Full Text] [Related]
11. Management of infections caused by WHO critical priority Gram-negative pathogens in Arab countries of the Middle East: a consensus paper. Al Salman J; Al Dabal L; Bassetti M; Alfouzan WA; Al Maslamani M; Alraddadi B; Elhoufi A; Enani M; Khamis FA; Mokkadas E; Romany I; Somily A; Kanj S Int J Antimicrob Agents; 2020 Oct; 56(4):106104. PubMed ID: 32721603 [TBL] [Abstract][Full Text] [Related]
12. The choice of antibacterial drugs. Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552 [No Abstract] [Full Text] [Related]
13. Colonization by antibiotic-resistant gram-negative bacteria and appropriate empirical antibiotic therapy in intensive care unit patients. Bellissimo-Rodrigues F; de Castro Figueiredo JF; Martinez R Infect Control Hosp Epidemiol; 2006 Jan; 27(1):104; author reply 105. PubMed ID: 16528869 [No Abstract] [Full Text] [Related]
15. Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy. Koliscak LP; Johnson JW; Beardsley JR; Miller DP; Williamson JC; Luther VP; Ohl CA Antimicrob Agents Chemother; 2013 Dec; 57(12):5918-23. PubMed ID: 24041892 [TBL] [Abstract][Full Text] [Related]
16. Associations Between Enteral Colonization With Gram-Negative Bacteria and Intensive Care Unit-Acquired Infections and Colonization of the Respiratory Tract. Frencken JF; Wittekamp BHJ; Plantinga NL; Spitoni C; van de Groep K; Cremer OL; Bonten MJM Clin Infect Dis; 2018 Feb; 66(4):497-503. PubMed ID: 29186403 [TBL] [Abstract][Full Text] [Related]
17. [Sulperazone in the treatment of severe infections in patients with cancer]. Mitrokhin SD Antibiot Khimioter; 2003; 48(3):26-9. PubMed ID: 12914118 [TBL] [Abstract][Full Text] [Related]